Wockhardt incorporates new step-down subsidiary in Ireland

Wockhardt Ltd, the pharmaceuticals major, on Tuesday, April 8, said that it incorporated a new step-down subsidiary, Wockhardt Antibiotics Ltd, in Ireland, with a capital of 100 euros.

The regulatory filing said that “Wockhardt Bio AG, a subsidiary of the company, has incorporated a new wholly owned subsidiary in Ireland by the name Wockhardt Antibiotics (Ireland) Limited. Consequent to the incorporation, Wockhardt Antibiotics (Ireland) Limited has become a step-down subsidiary of the company.”

Wockhardt Bio AG will hold 100% of the shares in Wockhardt Antibiotics Ltd.

The newly incorporated entity has a capital of 100 euros, divided into 100 shares, subscribed at one euro each via cash considerations.

The newly incorporated entity will help Wockhardt to channelise its antibiotic products across the European Union.

Wockhardt share performance

Shares of Wockhardt closed in the green at ₹1,264.05 apiece, up 4.20% on the National Stock Exchange (NSE) on Tuesday. The stock surged 5.51% to hit its intraday high of ₹1,279.90.

The stock lost 5.38% over the last week and 11.26% since the beginning of April. The scrip slumped 10.78% on a year-to-date (YTD) basis.

Wockhardt shares touched a 52-week high of ₹1,679.90 on February 6, 2025, and a one-year low of ₹490.15 on June 5, 2024.

Wockhardt Ltd has a total market capitalisation of ₹20,505.68 crore as of April 8 on the NSE.